81 Participants Needed

Resource® Support Plus for Malnutrition in Head and Neck Cancer Patients

VB
Overseen ByVickie Baracos
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: AHS Cancer Control Alberta
Stay on Your Current MedsYou can continue your current medications while participating
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Multimodal Nutrition Therapy, Resource® Support Plus for malnutrition in head and neck cancer patients?

Research shows that improving nutrition in head and neck cancer patients can lead to better treatment outcomes and reduce side effects. Studies highlight the importance of nutrition care, including immunonutrition, to support patients undergoing cancer treatment.12345

Is Resource® Support Plus safe for humans?

The research does not provide specific safety data for Resource® Support Plus, but it highlights the importance of nutritional support in reducing complications for head and neck cancer patients. Nutritional interventions, including oral nutritional supplements, are generally considered beneficial and safe for improving patients' nutritional status.678910

How is Multimodal Nutrition Therapy different from other treatments for malnutrition in head and neck cancer patients?

Multimodal Nutrition Therapy is unique because it focuses on providing comprehensive nutritional support before and during cancer treatment, which can help reduce complications and improve patient outcomes. This approach is particularly important for head and neck cancer patients who are often malnourished, and it involves a multidisciplinary team to ensure continuous and tailored nutritional care.611121314

What is the purpose of this trial?

This trial tests a special diet plan to help head and neck cancer patients eat enough. The diet includes two types of medical foods designed to provide necessary calories and nutrients, making it easier for patients to maintain their energy levels.

Research Team

VB

Vickie Baracos

Principal Investigator

Cross Cancer Institute, Alberta Health Services

Eligibility Criteria

This trial is for adults over 18 with squamous cell carcinoma of the oral cavity, oropharynx, larynx, or hypopharynx planning to undergo radical radiotherapy. They must be able to eat orally and have a performance status indicating they can carry out some activity. Excluded are those with certain other cancers, on conflicting trials, using tube feeding, having conditions affecting nutrient metabolism/absorption, untreated brain metastases, severe chronic illnesses or allergies to trial supplement ingredients.

Inclusion Criteria

I can eat and drink on my own without help.
I have a confirmed diagnosis of squamous cell carcinoma in the mouth or throat area and will undergo intensive radiotherapy.
Patients must have the ability to read, understand, and sign an informed consent and must be willing to comply with study treatment and follow-up
See 2 more

Exclusion Criteria

I have brain metastases that haven't been treated, or I've had treatment without current symptoms.
Enrolment in any other clinical protocol or investigational study with an interventional agent or assessments that may interfere with study procedures
Life expectancy <6 months
See 5 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive multimodal oral nutrition therapy or standard care during cancer treatment

7 weeks
Weekly consultations with a specialist oncology Registered Dietitian

Crossover Treatment

All patients receive the intervention arm; patients on standard care cross over to the intervention

6 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Multimodal Nutrition Therapy
  • Resource® Support Plus
Trial Overview The study tests if multimodal nutrition therapy helps patients maintain their calorie intake during cancer treatment. It compares the average energy consumed by patients receiving primary nutrition intervention plus adjuvant therapy (Resource® Support Plus) against a control group throughout their treatment period.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Multimodal Nutrition TherapyExperimental Treatment1 Intervention
To assess a multimodal nutrition therapy (primary nutrition intervention+ adjuvant nutrition therapy) with features adapted for patients with cancers of the head and neck receiving chemo-radiotherapy treatment, to maintain oral dietary intake during treatment. The regimen consists of 2 medical foods, each taken on an unrestricted basis (as and when preferred by each patient). Resource® Support Plus, a nutritionally complete Medical Food specifically for the dietary management of oncology patients with (risk of) malnutrition. BOOST® Soothe, a Medical Food formulated as a clear oral nutritional supplement for cancer patients with sensory alterations or oral discomfort due to cancer treatments, in particular chemo- and/or radiotherapy.
Group II: Standard of CareActive Control1 Intervention
In this setting patients rely on oral dietary intake. Ordinary, commercially available ingredients and food products are consumed. The standard of care includes weekly consultation with specialist oncology Registered Dietitian.

Find a Clinic Near You

Who Is Running the Clinical Trial?

AHS Cancer Control Alberta

Lead Sponsor

Trials
188
Recruited
26,900+

Findings from Research

The Eating As Treatment (EAT) program, which trains dietitians to use psychological techniques, significantly improved nutritional status in head and neck cancer patients undergoing radiation therapy, as evidenced by better scores on the Patient-Generated Subjective Global Assessment at the end of treatment.
Patients receiving the EAT intervention experienced not only improved nutrition but also a higher likelihood of being well-nourished, less weight loss, fewer treatment interruptions, lower depression scores, and a better quality of life compared to those receiving standard care.
Eating As Treatment (EAT): A Stepped-Wedge, Randomized Controlled Trial of a Health Behavior Change Intervention Provided by Dietitians to Improve Nutrition in Patients With Head and Neck Cancer Undergoing Radiation Therapy (TROG 12.03).Britton, B., Baker, AL., Wolfenden, L., et al.[2019]
Head and neck cancer patients (n = 114) often did not meet the recommended dietary intakes for essential vitamins and minerals throughout their treatment, indicating a need for improved nutritional support.
Patients who consumed more oral nutritional supplements (ONS) had higher micronutrient intakes and Nutrition Impact Scores, but they also experienced greater weight loss, suggesting that while ONS can help with nutrient intake, they may not prevent weight loss during treatment.
Head and Neck Cancer Patients Do Not Meet Recommended Intakes of Micronutrients without Consuming Fortified Products.Nejatinamini, S., Kubrak, C., Álvarez-Camacho, M., et al.[2019]

References

Eating As Treatment (EAT): A Stepped-Wedge, Randomized Controlled Trial of a Health Behavior Change Intervention Provided by Dietitians to Improve Nutrition in Patients With Head and Neck Cancer Undergoing Radiation Therapy (TROG 12.03). [2019]
Effects of Immunonutrition in Head and Neck Cancer Patients Undergoing Cancer Treatment - A Systematic Review. [2022]
"Completely and utterly flummoxed and out of my depth": patient and caregiver experiences during and after treatment for head and neck cancer-a qualitative evaluation of barriers and facilitators to best-practice nutrition care. [2021]
A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer. [2022]
Evaluation of a novel pre-treatment model of nutrition care for patients with head and neck cancer receiving chemoradiotherapy. [2022]
Nutritional management of the head and neck cancer patient. [2019]
Toxicities Caused by Head and Neck Cancer Treatments and Their Influence on the Development of Malnutrition: Review of the Literature. [2021]
Pre-therapeutic nutritional assessment for predicting severe adverse events in patients with head and neck cancer treated by radiotherapy. [2022]
Head and Neck Cancer Patients Do Not Meet Recommended Intakes of Micronutrients without Consuming Fortified Products. [2019]
Consensus and clinical recommendations for nutritional intervention for head and neck cancer patients undergoing chemoradiotherapy in Taiwan. [2019]
[Value of a nutrition score in patients with advanced carcinomas in the area of the head and neck]. [2019]
Whole-course nutritional support therapy and indicators in head and neck cancer surgery. [2022]
Dietary and nutritional needs of patients undergoing therapy for head and neck cancer. [2019]
14.United Statespubmed.ncbi.nlm.nih.gov
Nutritional assessment of the head and neck cancer patient. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security